Saturn V Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Saturn V Capital Management's JAZZ Position: Q2 2026 in Review
Saturn V Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.2% in Q2 2026, selling an estimated $443K and leaving 160,938 shares worth $38.8M. The position accounts for 5.56% of the portfolio, ranked #7.
Saturn V Capital Management first reported a position in JAZZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $42.2M in Q4 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Saturn V Capital Management held 160,938 shares of Jazz Pharmaceuticals worth $38.8M as of Q2 2026.
- Saturn V Capital Management sold 2,023 Jazz Pharmaceuticals shares in Q2 2026, an estimated $443K.
- Jazz Pharmaceuticals made up 5.56% of Saturn V Capital Management's portfolio in Q2 2026, its #7 holding.
- Saturn V Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- Saturn V Capital Management's Jazz Pharmaceuticals position peaked at $42.2M in Q4 2025.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Saturn V Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.